P624: PHASE 1 STUDY OF JNJ-67856633, A FIRST-IN-HUMAN HIGHLY SELECTIVE MALT1 INHIBITOR, IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

• Matko Kalac,
• Mark Hertzberg,
• Chan Cheah,
• Vincent Ribrag,
• Pablo Abrisquet Acosta,
• Stephen Opat,
• Emmanuel Bachy,
• Loïc Ysebaert,
• Lihua Qiu,
• Shuhua Yi,
• Noriko Nishimura,
• Charlotte Lemech,
• Jacqueline Bussolari,
• Changchun Deng,
• Tianbao Lu,
• Liang Xiu,
• Sandy Van Hemelryck,
• Ulrike Philippar,
• Yue Guo,
• Virginie Soete,
• Isabel Soriano,
• Nele Fourneau,
• John Gerecitano,
• Franck Morschhauser

Affiliations

Matko Kalac

1 UCI Health Chao Family Comprehensive Cancer Center, Orange, United States

Mark Hertzberg

2 Scientia Clinical Research, Randwick, Australia

Chan Cheah

3 Sir Charles Gairdner Hospital, Nedlands, Australia

Vincent Ribrag

4 Institute Gustave Roussy Chevilly-Larue, Chevilly-Larue, France

Pablo Abrisquet Acosta

5 Vall d’Hebron University Hospital, Barcelona, Spain

Stephen Opat

6 Monash University, Faculty of Medicine, Nursing and Health Sciences, Clayton, Australia

Emmanuel Bachy

7 Lyon Sud Hospital Center, Pierre-Bénite, France

Loïc Ysebaert

8 IUCT Oncopole, Toulouse, France

Lihua Qiu

9 Tianjin Medical University Cancer Institute and Hospital, China

Shuhua Yi

10 China Academy of Medical Science, Institute of Hematology and Blood Disease Hospital, Tianjin, China

Noriko Nishimura

11 Japanese Foundation for Cancer Research, Koto City, Japan

Charlotte Lemech

2 Scientia Clinical Research, Randwick, Australia

Jacqueline Bussolari

12 Janssen Research & Development, Spring House, United States

Changchun Deng

12 Janssen Research & Development, Spring House, United States

Tianbao Lu

12 Janssen Research & Development, Spring House, United States

Liang Xiu

12 Janssen Research & Development, Spring House, United States

Sandy Van Hemelryck

13 Janssen Research & Development, Beerse, Belgium

Ulrike Philippar

13 Janssen Research & Development, Beerse, Belgium

Yue Guo

12 Janssen Research & Development, Spring House, United States

Virginie Soete

13 Janssen Research & Development, Beerse, Belgium

Isabel Soriano

14 Janssen-Cilag, Madrid, Spain

Nele Fourneau

13 Janssen Research & Development, Beerse, Belgium

John Gerecitano

12 Janssen Research & Development, Spring House, United States

Franck Morschhauser

15 Hospital Claude Huriez, Lille, France